Dr. Thomas Love Prendergast Dentist Medicare: Not Enrolled in Medicare Practice Location: 1394 S Route 12, Fox Lake, IL 60020 Phone: 847-587-5053 |
Dr. Carlton Bruce Hagstrom, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 208 S Us Highway 12, Fox Lake, IL 60020 Phone: 847-587-5400 Fax: 847-587-5400 |
Dr. Daniel Choo, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1250 S Us Highway 12, Fox Lake, IL 60020 Phone: 847-587-6600 Fax: 847-587-6618 |
Dr. Donald Saltzman, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1250 S Us Highway 12, Fox Lake, IL 60020 Phone: 847-587-6600 Fax: 847-587-6618 |
Dr. Caroline Shepherd, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1394 S Route 12, Fox Lake, IL 60020 Phone: 847-587-5053 |
News Archive
Despite the great promise that injecting a new type of anti-inflammatory pain medicine into the spine could relieve the severe leg and lower back pain of sciatica, a Johns Hopkins-led study has found that the current standard of care with steroid injections still does better.
Haemonetics Corporation, a global blood management solutions company, and Engineering and Research Associates Inc. (known as "SEBRA(R)"), a leading provider of blood and medical manufacturing technologies, announced today that Haemonetics has acquired the assets of SEBRA's blood collection and processing business for $12.5 million cash. The acquisition is expected to close within the next several weeks.
The Obama administration has announced a bold research program to test whether a drug can prevent the onset of Alzheimer's disease well before any symptoms appear. It is a long shot, but the payoff could be huge.
Oral and genital herpes are caused by the herpes simplex virus type 1 (HSV-1) and the herpes simplex virus type 2 (HSV-2), which both cause lifelong infection. HSV-2 infection is associated with increased risk for HIV infection.
Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer Dr. Chris Yu announced that Venture Capital (VC) Firm, Shanghai Zhangjiang Science &Technology Investment Corporation (ZJSTIC), as well as private investors related to the insurance industry, have again invested over $2 Million to support Anpac's "Cancer Differentiation Analysis" (CDA) technology.
› Verified 3 days ago